Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers-Reference-Cited by-同舟云学术

Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers

Published:2018-08 Issue:8 Volume:56 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Marques Adriana R.¹^ORCID

Affiliation:

1. Lyme Disease Studies Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

Abstract

Lyme disease is a tick-borne illness caused by Borreliella ( Borrelia ) burgdorferi , and it is the most common vector-borne disease in the United States, with an estimated incidence of 300,000 cases per year. The currently recommended approach for laboratory support of the diagnosis of Lyme disease is a standard two-tiered (STT) algorithm comprised of an enzyme-linked immunoassay (EIA) or immunofluorescence assay (IFA), followed by Western blotting (WB).

Funder

NIAID/NIH

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00749-18

Reference35 articles.

1. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

2. Editorial Commentary:Laboratory Testing for Lyme Disease: Time for a Change?

3. Prospective Study of Serologic Tests for Lyme Disease